Top
CTTNBP2NL has not been detected as a mutational cancer driver

CTTNBP2NL
Ensembl id ENSG00000143079
Mutated samples
Coding Sequence 47 (0.7%)
Protein Affecting 35 (0.5%)
Mode of action Unclassified
Known driver No
Cancer type Signals (Biases)
Clust Clustered Mutations FM Functional Mutations Rec Recurrent Mutations
This plot shows the most recurrently mutated cancer types in all CTTNBP2NL gene mutations. Each bar of the histogram indicates the amount of samples with PAMs.

Cancer type Driver Mutated samples (CS) Mutated samples (PAM) % Mutated samples (PAM)
Cutaneous melanoma No 12 9 2.44
Lung squamous cell carcinoma No 7 6 3.45
Breast carcinoma No 5 4 0.35
Lung adenocarcinoma No 3 3 0.77
Uterine corpus endometrioid carcinoma No 3 2 0.87
Chronic lymphocytic leukemia No 3 2 0.69
Stomach adenocarcinoma No 2 2 1.24
Head and neck squamous cell carcinoma No 2 2 0.53
Bladder carcinoma No 2 1 1.02
Renal clear cell carcinoma No 1 1 0.24
Serous ovarian adenocarcinoma No 1 1 0.32
Small cell lung carcinoma No 1 1 1.45
Glioblastoma multiforme No 1 1 0.26
Hepatocarcinoma No 2 0 0.00
Acute myeloid leukemia No 1 0 0.00
Colorectal adenocarcinoma No 1 0 0.00
The mutations needle plot shows the distribution of the observed cancer mutations along the protein sequence and it's possible mutational clusters and hotspots. The needles' height and head size represent mutational recurrence. Needles of different categories that fall in the same amino acid residues are stacked.

Variant Locus Samples AA pos AA change Consequence